Your source for the latest medtech news from AdvaMed® and our members.
This week, AdvaMed®, the Medtech Association, hosted an Artificial Intelligence (AI) Demonstration Day event on Capitol Hill showcasing AI-enabled medical devices and technologies from leading health care companies. The event…
Today, AdvaMed® President and CEO Scott Whitaker released the following statement about U.S. Food and Drug Administration Center for Devices and Radiological Health Director, Dr. Jeff Shuren.
MedTechVets, a leading non-profit organization dedicated to supporting military veterans in transitioning into careers in the medical technology sector, proudly announces Mary McLoughlin will be consulting as Strategic Advisor effective…
Neuspera Medical, Inc., a neuromodulation company pioneering the Neuspera Implantable Sacral Neuromodulation (SNM) System, announced the closing of its Series D funding round raising $23 million and led by Vertex…
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
Today, the Centers for Medicare and Medicaid Services (CMS) issued the Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule for CY25, which includes significant wins…
The Wisconsin Biohealth Tech Hub, led by BioForward Wisconsin, achieves a significant milestone as a Phase 2 recipient of the U.S. Department of Commerce’s Economic Development Administration (EDA) Regional Technology…
In the newest episode of Medtech POV, Steve Mapa, President and Executive Director of MedTechVets, joins host Scott Whitaker to talk about his career in the United States Army and…
The House Ways and Means Committee voted to pass the bipartisan H.R. 1691, Ensuring Patient Access to Critical Breakthrough Products Act, during a markup meeting.
Brought to you by AdvaMed®, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
UroMems, a global company developing innovative, implantable mechatronics technology to treat stress urinary incontinence (SUI), today announced it has raised $47 million in its Series C financing, the largest fundraising…